INS and Alzheimer disease: The downregulated brain insulin in T2D weakens the activity of insulin signaling and over-activates the GSK-3β to hyperphosphorylated tau, contributing to occurrence and progression of AD (Noble et al. 2013; Yang et al. 2013).